Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Cytokinetics (CYTK)

Cytokinetics (CYTK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Cytokinetics to Announce Third Quarter Results on November 6, 2024

CYTK : 51.82 (+1.61%)
Cytokinetics Highlights Progress in Cardiac Myosin Modulation Programs and Global Commercial Launch Readiness at Investor & Analyst Day

CYTK : 51.82 (+1.61%)
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

CYTK : 51.82 (+1.61%)
Analysts Think There's Still Time to Get in on Edgewise, Up 332%

Edgewise Therapeutics was a massive winner last week after positive results on its cardiovascular treatment. This there still room for the stock to run?

CYTK : 51.82 (+1.61%)
EWTX : 34.00 (+1.28%)
BMY : 54.32 (-2.60%)
Cytokinetics: Q2 Earnings Snapshot

Cytokinetics: Q2 Earnings Snapshot

CYTK : 51.82 (+1.61%)
Cytokinetics: Q1 Earnings Snapshot

Cytokinetics: Q1 Earnings Snapshot

CYTK : 51.82 (+1.61%)
2 Incredible Growth Stocks to Buy Right Now

These two biotech stocks could be big winners in the years ahead.

CYTK : 51.82 (+1.61%)
VKTX : 72.88 (+0.47%)
Cytokinetics: Q4 Earnings Snapshot

Cytokinetics: Q4 Earnings Snapshot

CYTK : 51.82 (+1.61%)
Markets Today: Stocks Slip on Hawkish Fed Comments

Morning Markets March E-Mini S&P 500 futures (ESH24 ) are down -0.30%, and March Nasdaq 100 E-Mini futures (NQH24 ) are down -0.19%. Stock index futures this morning are mildly lower as higher bond yields...

ESZ24 : 5,758.25s (+0.34%)
NQZ24 : 20,153.25s (+0.66%)
BA : 154.59 (+3.54%)
APD : 309.21 (-0.43%)
ZS : 182.59 (+1.00%)
MAT : 19.91 (-2.31%)
CYTK : 51.82 (+1.61%)
GWW : 1,105.07 (-0.38%)
CAT : 379.63 (+0.91%)
EL : 66.58 (-3.42%)
FDMT : 8.10 (+1.06%)
CTLT : 58.73 (+0.22%)
2 Biotechs That Could Get Bought Out in 2024

These two biotechs have been frequent visitors to the buyout-rumor mill and for good reason.

CYTK : 51.82 (+1.61%)
BBIO : 25.48 (+8.84%)

Barchart Exclusives

3 ETFs to Ride the Tesla Wave and the EV Revolution
The electric vehicle (EV) sector is gaining momentum, with Tesla's recent performance sparking renewed interest in the space. Three ETFs - KARS, DRIV, and TSLL - offer investors different ways to tap into the EV trend, with each fund providing a unique blend of exposure to traditional automakers, tech innovators, and other players in the EV ecosystem. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar